|
Granite Construction Company was incorporated in 1922. In 1990, Granite Construction Incorporated was formed as the holding company for Granite Construction Company and its wholly-owned and consolidated subsidiaries and was incorporated in Delaware. Unless otherwise indicated, the terms “we,” “us,” “our,” “Company” and “Granite” refer to Granite Construction Incorporated and its wholly-owned and consolidated subsidiaries. We deliver infrastructure solutions for public and private clients primarily in the United States. We are one of the largest diversified infrastructure companies in the United States. Within the public sector, we primarily concentrate on infrastructure projects, including the construction of streets, roads, highways, mass transit facilities, airport infrastructure, bridges, dams, power-related facilities, utilities, tunnels and other infrastructure-related projects. Within the private sector, we perform site preparation, mining services, and infrastructure services for residential development, energy development, commercial and industrial sites, and other facilities, as well as provide construction management professional services.
2-28-2022 |
Mr. Kyle T. Larkin
Chief Executive Officer Granite Construction Incorporated 585 West Beach Street Watsonville, CA 95076 United States 831-724-1011 graniteconstruction.com NYSE Stock Symbol GVA |
|
Guidewire delivers a leading platform that Property and Casualty (“P&C”) insurers trust to engage, innovate, and grow efficiently. Guidewire’s platform combines core operations, digital engagement, analytics, and artificial intelligence (“AI”) applications delivered as a cloud service or self-managed software. As a partner to our customers, we continually evolve to enable their success and assist them in navigating a rapidly changing insurance market.
9-24-2021 |
Mr. Marcus S. Ryu
President Guidewire Software, Inc 1001 East Hillsdale Boulevard Suite 800 Foster City, CA 94404 United States 650-357-9100 http://www.guidewire.com NYSE Stock Symbol GWRE |
|
We are a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs. Our advanced science, patented technologies, and innovative approach to drug discovery and development have allowed us to create and commercialize a portfolio of products that aim to advance the standard of care for acute care and oncology patients.
2-28-2022 |
Dr. Barry D. Quart
CEO Heron Therapeutics, Inc 4242 Campus Point Court Suite 200 San Diego, CA 92121 United States 858 251 4400 http://www.herontx.com Nasdaq Stock Symbol HRTX |